To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19
Clinical trial NCT04524052 · UNKNOWN
Trial details
- NCT number
- NCT04524052
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2020-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.